✦ LIBER ✦

Molecular Pathways: Adaptive Kinome Reprogramming in Response to Targeted Inhibition of the BRAF-MEK-ERK Pathway in Cancer

✍ Scribed by Johnson, G. L.; Stuhlmiller, T. J.; Angus, S. P.; Zawistowski, J. S.; Graves, L. M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of Raf Kinase in Cancer: Therapeuti

✍ Jared A. Gollob; Scott Wilhelm; Chris Carter; Susan L. Kelley 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 803 KB

Targeting the PI3K/AKT/mTOR and Raf/MEK/

✍ Saini, Kamal S.; Loi, Sherene; de Azambuja, Evandro; Metzger-Filho, Otto; Saini, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 924 KB

Involvement of MEK–ERK signaling pathway

✍ Wataru Motomura; Satoshi Tanno; Nobuhiko Takahashi; Miho Nagamine; Mitsuko Fukud 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Molecular oncology in lung cancer – betw

✍ W. Berger; A. Pircher; M. Sibilia; L. Bubendorf; M. Filipits; M. Fiegl; M. Früh; 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 561 KB

Chronic inhibition of the MEK/ERK pathwa

✍ Bose, Suchira; Cavallini, Annalisa; Murray, Tracey; Baschirotto, Lisa; Czilli, D 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

QS282. BRAF Mutation Status, But not ERK

✍ Jonathan C. Samuel; Elizabeth D. Routh; Channing J. Der; Jen Jen Yeh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 48 KB